1-5 of 5
Adriano Salaroli, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Interim Results from the Phase I Deplethink Trial Evaluating the Infusion of a NKG2D CAR T-Cell Therapy Post a Non-Myeloablative Conditioning in Relapse or Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients

A. Samer Al-Homsi, MD, Enkhtsetseg Purev, MD PhD, Philippe Lewalle, Maher Abdul-Hay, MD, Daniel A Pollyea, MD, Adriano Salaroli, MD, Thomas Lequertier, Erik Alcantar-Orozco, MD, Fabian Borghese, Caroline Lonez, PhD, Nathalie Braun, Florence Renard, Anne Flament, MD, Ine Moors, MD, Tessa Kerre
Journal: Blood
Blood (2019) 134 (Supplement_1): 3844.
https://doi.org/10.1182/blood-2019-128267
Published: 2019
Journal Articles

Outcome of Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) and/or 17p Deletion/ TP 53 Mutations Treated with Ibrutinib According to a Named Patient Program (NPP) in Italy: Preliminary Analysis of a Real Life Retrospective Study

Francesca Romana Mauro, MD PhD, Alessandra Tedeschi, Alfonso Piciocchi, BS, Marina Motta, MD, Emilia Iannella, MD, Lucia Farina, MD PhD, Lydia Scarfo, Roberto Marasca, MD, Marta Coscia, MD PhD, Agostino Cortelezzi, MD, Luca Laurenti, Angela Melpignano, MD, Pier Luigi Zinzani, MD PhD, Stefano Molica, MD, Francesca Re, MD, Alessandro Andriani, MD, Donatella Iolanda Vincelli, MD, Carlo Visco, MD, Alessandro Gozzetti, MD, Ester Maria Orlandi, MD, Livio Trentin, MD, Monica Tani, Catello Califano, MD, Giuseppe Tagariello, MD, Paolo Ghia, MD PhD, Maria Denise Caputo, MD, Adriano Salaroli, MD, Idanna Innocenti, MD, Anna Frustaci, MD, Candida Vitale, MD, Marta Petullà, PharmD, Paolo de Fabritiis, MD, Marco Vignetti, MD, Paola Fazi, MD, Robin Foà
Journal: Blood
Blood (2016) 128 (22): 2038.
https://doi.org/10.1182/blood.V128.22.2038.2038
Published: 2016
Journal Articles

Exclusion Criteria In The Dasision and Enestnd Trials: Which Could Their Impact Be On The Front-Line Treatment Of a “Real-life” Patient Population With Chronic Myelogenous Leukemia?

Roberto Latagliata, MD, Ida Carmosino, Federico Vozella, Paola Volpicelli, MD, Giuseppina Loglisci, Michelina Santopietro, Adriano Salaroli, MD, Angela Romano, Chiara Montagna, Amanda Roberto, Alessandra Serrao, Daniela Diverio, PhD, Mauro Nanni, PhD, Marco Mancini, Agostino Tafuri, Massimo Breccia, Giuliana Alimena, MD
Journal: Blood
Blood (2013) 122 (21): 4002.
https://doi.org/10.1182/blood.V122.21.4002.4002
Published: 2013
Journal Articles

Delayed Cytogenetic Response and Reduced Rate of Major Molecular Response Associated to Increased Body Mass Index At Baseline in Chronic Phase Chronic Myeloid Leukemia Patients Treated with Imatinib.

Massimo Breccia, Giuseppina Loglisci, MD, Adriano Salaroli, MD, Alessandra Serrao, MD, Paola Volpicelli, MD, Daniela Diverio, PhD, Roberto Latagliata, MD, Giuliana Alimena
Journal: Blood
Blood (2012) 120 (21): 2784.
https://doi.org/10.1182/blood.V120.21.2784.2784
Published: 2012
Journal Articles

Long-Term Follow-up of Chronic Phase Chronic Myeloid Leukemia Patients Who Failed Interferon Alpha and Switched to Imatinib

Massimo Breccia, Giuseppina Loglisci, MD, Adriano Salaroli, MD, Alessandra Serrao, MD, Irene Zacheo, MD, Roberto Latagliata, MD, Giuliana Alimena
Journal: Blood
Blood (2012) 120 (21): 3742.
https://doi.org/10.1182/blood.V120.21.3742.3742
Published: 2012